• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

RedHawk Agrees to Purchase Med Tech Farms LLC

Share:

February 16, 2021

RedHawk Holdings Corp. (OTC: SNDD) (“RedHawk” or the “Company”), a diversified holding company primarily engaged in sales and distribution of medical devices, announced today that its wholly-owned subsidiary, RedHawk Pharma LLC, has agreed to acquire certain cannabis assets of Med Tech Farms LLC (“Med Tech”), an Oklahoma-based start-up grower and supplier of cannabis products for a total of $1 million to be paid through a combination of cash, stock and convertible notes. The assets to be acquired include, but are not limited to, the licenses to grow, manufacture, transport and sell cannabis products in the State of Oklahoma, with an anticipated initial focus on “craft” cultivation and distribution.

Commenting on the acquisition, G. Darcy Klug, RedHawk’s Chairman and Chief Financial Officer, said, “We are really excited about the anticipated Med Tech acquisition, its management team and the potential for strong and exciting strategic organic growth opportunities for RedHawk, not only in Oklahoma, but in other states as well.”

A closing, is expected to occur before March 31, 2021 and is contingent upon, among other things, approval by RedHawk’s board of directors, the negotiation, acceptance and execution of a final definitive purchase agreement, acceptance and approval by the board of directors and the shareholders of the seller, satisfactory completion of legal and financial due diligence, RedHawk obtaining the required amount of acquisition financing, and the obtainment of all necessary consents and approvals of any third parties.

Source: Biospace

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Clarius Unveils Ultra-High Frequency Handheld Ultrasound ScannerClarius Unveils Ultra-High Frequency Handheld Ultrasound Scanner
  • VA, Philips to Create World’s Largest Tele-Critical Care System for VeteransVA, Philips to Create World’s Largest Tele-Critical Care System for Veterans
  • FIGUR8 Launches with $7.5M in Seed Funding to Help Clinicians Make Better Informed Clinical Decisions through Advanced Human Movement DataFIGUR8 Launches with $7.5M in Seed Funding to Help Clinicians Make Better Informed Clinical Decisions through Advanced Human Movement Data
  • The Post-COVID Italian Telehealth ExperienceThe Post-COVID Italian Telehealth Experience
  • Centene and WellCare Announce Five Additional State Insurance Department Approvals for Pending MergerCentene and WellCare Announce Five Additional State Insurance Department Approvals for Pending Merger
  • North American M&A Hits Near-Record Volume in Q2’21 as Resurgence ContinuesNorth American M&A Hits Near-Record Volume in Q2’21 as Resurgence Continues
  • Catalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIIICatalyst Pharmaceuticals Completes the Acquisition of U.S. Rights to FYCOMPA® (Perampanel) CIII
  • Heartseed Raises $26m in Series B Funding to Accelerate Development of Ipsc-derived Regenerative Medicine for Heart FailureHeartseed Raises $26m in Series B Funding to Accelerate Development of Ipsc-derived Regenerative Medicine for Heart Failure

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications